<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>Antigenic variants of M2e fragments</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Major feature</th>
    <th>2</th>
    <th>3</th>
    <th>4</th>
    <th>5</th>
    <th>6</th>
    <th>7</th>
    <th>8</th>
    <th>9</th>
    <th>10</th>
    <th>11</th>
    <th>12</th>
    <th>13</th>
    <th>14</th>
    <th>15</th>
    <th>16</th>
    <th>17</th>
    <th>18</th>
    <th>19</th>
    <th>20</th>
    <th>21</th>
    <th>22</th>
    <th>23</th>
    <th>24</th>
    <th>Reference</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>The most conservative part of M2e</td>
    <td>S</td>
    <td>L</td>
    <td>L</td>
    <td>T</td>
    <td>E</td>
    <td>V</td>
    <td>E</td>
    <td>T</td>
    <td>P</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td>[
     <xref ref-type="bibr" rid="CR18">18</xref>, 
     <xref ref-type="bibr" rid="CR51">51</xref>]
    </td>
   </tr>
   <tr>
    <td>TCN-031 and TCN-032 antibodies recognition site</td>
    <td>S</td>
    <td>L</td>
    <td>L</td>
    <td>T</td>
    <td>E</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td>[
     <xref ref-type="bibr" rid="CR37">37</xref>]
    </td>
   </tr>
   <tr>
    <td>O19 antibody recognition site</td>
    <td>S</td>
    <td>L</td>
    <td>L</td>
    <td>T</td>
    <td>E</td>
    <td>V</td>
    <td>E</td>
    <td>T</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td valign="middle" rowspan="3">[
     <xref ref-type="bibr" rid="CR32">32</xref>]
    </td>
   </tr>
   <tr>
    <td>L18 antibody recognition site</td>
    <td/>
    <td/>
    <td>L</td>
    <td>T</td>
    <td>E</td>
    <td>V</td>
    <td>E</td>
    <td>T</td>
    <td>P</td>
    <td>I</td>
    <td>R</td>
    <td>N</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>S1 antibody recognition site</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td>V</td>
    <td>E</td>
    <td>T</td>
    <td>P</td>
    <td>I</td>
    <td>R</td>
    <td>N</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>Influenza A and B virus neutralizing activity in vitro</td>
    <td>S</td>
    <td>L</td>
    <td>L</td>
    <td>T</td>
    <td>E</td>
    <td>V</td>
    <td>E</td>
    <td>T</td>
    <td>P</td>
    <td>I</td>
    <td>R</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td>[
     <xref ref-type="bibr" rid="CR77">77</xref>]
    </td>
   </tr>
   <tr>
    <td>Presence of B-cell epitope and 14C2 antibody recognition site</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td>E</td>
    <td>V</td>
    <td>E</td>
    <td>T</td>
    <td>P</td>
    <td>I</td>
    <td>R</td>
    <td>N</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td>[
     <xref ref-type="bibr" rid="CR78">78</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <p>High affinity of binding with HLA-A2;</p>
     <p>presence of T-cell epitope</p>
    </td>
    <td/>
    <td>L</td>
    <td>L</td>
    <td>T</td>
    <td>E</td>
    <td>V</td>
    <td>E</td>
    <td>T</td>
    <td>P</td>
    <td>I</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td>[
     <xref ref-type="bibr" rid="CR36">36</xref>]
    </td>
   </tr>
   <tr>
    <td>Potential epitope</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td>E</td>
    <td>T</td>
    <td>P</td>
    <td>I</td>
    <td>R</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td valign="middle" rowspan="3">[
     <xref ref-type="bibr" rid="CR94">94</xref>]
    </td>
   </tr>
   <tr>
    <td>Presence of CTL-cell epitopes</td>
    <td>S</td>
    <td>L</td>
    <td>L</td>
    <td>T</td>
    <td>E</td>
    <td>V</td>
    <td>E</td>
    <td>T</td>
    <td>P</td>
    <td>I</td>
    <td>R</td>
    <td>N</td>
    <td>E</td>
    <td>W</td>
    <td>G</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>Some critical residues for T-helpers</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td>C</td>
    <td>R</td>
    <td>C</td>
    <td>N</td>
    <td>D</td>
    <td>S</td>
    <td>S</td>
    <td>D</td>
   </tr>
   <tr>
    <td>Recognition of HLA-B44-restricted CD8+ CTL line 124</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td>V</td>
    <td>E</td>
    <td>T</td>
    <td>P</td>
    <td>I</td>
    <td>R</td>
    <td>N</td>
    <td>E</td>
    <td>W</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td>[
     <xref ref-type="bibr" rid="CR52">52</xref>]
    </td>
   </tr>
   <tr>
    <td>MHC class II H-2d-restricted epitope</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td>E</td>
    <td>T</td>
    <td>P</td>
    <td>I</td>
    <td>R</td>
    <td>N</td>
    <td>E</td>
    <td>W</td>
    <td>G</td>
    <td>S</td>
    <td>R</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td>[
     <xref ref-type="bibr" rid="CR26">26</xref>]
    </td>
   </tr>
   <tr>
    <td>L66 antibody recognition site</td>
    <td>S</td>
    <td>L</td>
    <td>L</td>
    <td>T</td>
    <td>E</td>
    <td>V</td>
    <td>E</td>
    <td>T</td>
    <td>P</td>
    <td>I</td>
    <td>R</td>
    <td>N</td>
    <td>E</td>
    <td>W</td>
    <td>G</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td valign="middle" rowspan="5">[
     <xref ref-type="bibr" rid="CR128">128</xref>]
    </td>
   </tr>
   <tr>
    <td>N547 antibody recognition site</td>
    <td/>
    <td>L</td>
    <td>L</td>
    <td>T</td>
    <td>E</td>
    <td>V</td>
    <td>E</td>
    <td>T</td>
    <td>P</td>
    <td>I</td>
    <td>R</td>
    <td>N</td>
    <td>E</td>
    <td>W</td>
    <td>G</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>Z3G1 antibody recognition site</td>
    <td/>
    <td>L</td>
    <td>L</td>
    <td>T</td>
    <td>E</td>
    <td>V</td>
    <td>E</td>
    <td>T</td>
    <td>P</td>
    <td>I</td>
    <td>R</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>C40G1 antibody recognition site</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td>T</td>
    <td>P</td>
    <td>I</td>
    <td>R</td>
    <td>N</td>
    <td>E</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>14C2 antibody recognition site</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td>E</td>
    <td>V</td>
    <td>E</td>
    <td>T</td>
    <td>P</td>
    <td>I</td>
    <td>R</td>
    <td>N</td>
    <td>E</td>
    <td>W</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
   </tr>
  </tbody>
 </table>
</table-wrap>
